360Dx

Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

Array Genomics Sets Out to Build Business for Bladder Cancer Test

Premium

The British molecular diagnostics company received a CE-IVD mark for the assay, called BCA-1, in June, and launched the test in October.

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Veracyte has also acquired Nanostring's Prosigna breast cancer and LymphMark lymphoma assays and plans to develop diagnostic tests using the nCounter platform.

NanoString-Based Genotype, Phenotype Test Rapidly Detects Antimicrobial Resistance

Premium

The method, dubbed GoPhAST-R, was codeveloped by researcher from the Broad Institute and NanoString, which now hopes to work with a partner to commercialize it.

Quotient Prices $78.4M Public Offering of Shares

The company said it intends to use the proceeds of the offering to advance its MosaiQ high-throughput automated testing products, among other things.

Nov 06, 2019

Quanterix Q3 Revenues Increase 41 Percent

Nov 04, 2019

Quotient Limited Fiscal Q2 Revenues Rise 26 Percent

Nov 01, 2019

Local Coverage Determinations Roundup: Transplant Genomics

Oct 29, 2019

Mobidiag Inks Distribution Agreements in Europe, Middle East for Dx Products

Sep 06, 2019

Specific Diagnostics Secures $12.5M in Funding

Aug 28, 2019

SQI Diagnostics Q2 Revenues Tick Up Sharply

Aug 05, 2019

Quotient Fiscal Q1 Revenues Grow 4 Percent

Aug 01, 2019

MBio Awarded $1M NIH Grant to Develop Point-of-Care Sepsis Assay

Jul 17, 2019

PathogenDx, Nationwide Laboratory Services Partner on Fungal Testing

Jul 11, 2019

Cancer Detection Firm StageZero Raises C$2.7M

Jul 02, 2019

Noninvasive Endometriosis Test Developer DotLab Secures $10M in Series A Funding

Jun 28, 2019

Akonni Biosystems Developing Multi-Target Infectious Diseases Tests for Newly Cleared TruDx System

Premium

May 28, 2019

Quotient Fiscal Q4 Revenues Grow 36 Percent

May 24, 2019

Custom NanoString Assay Detects Bowel Cancer Subtypes, May Help Guide Therapies

Premium

May 21, 2019

Agendia, Imegen Ink Distribution Deal for Breast Cancer Tests in Spain, Portugal

May 09, 2019

NanoString Revenues Climb 18 Percent in Q1

May 08, 2019

Almac Assay's Ability to Stratify Esophageal Cancer Patients Demonstrated by UK Researchers

Premium

May 02, 2019

Quotient Gets CE Mark for Immunohematology Microarray

May 01, 2019

Stroke Test Being Developed to Detect Cause, Enable Better Treatment

Premium

Apr 30, 2019

InDevR Gets FDA 510(k) Clearance for Influenza Assay